| VML | volumetric muscle loss |
| ECM | extracellular matrix |
| FDA | Food and Drug Administration |
| μm | micrometer |
| MRFs | myogenic regulatory factors |
| bHLH | Basic Helix-Loop-Helix |
| MyoD | myogenic differentiation 1 |
| DMD | Duchenne Muscular Dystrophy |
| FFMT | free functional muscle transfer |
| GelMA | gelatin methacrylate |
| RGD | arginylglycylaspartic Acid |
| CNTs | carbon nanotubes |
| PPY | polypyrrole |
| PANI | polyaniline |
| ES | electrospinning |
| iPSCs | Induced Pluripotent Stem Cells |
| hESCs | human embryonic stem cells |
| NMJ | neuromuscular junction |
| MSCs | mesenchymal stem cells |
| ADSCs | adipose-derived stem cells |
| MPC-Exo | Myogenic Progenitor Cell-Derived Exosomes |
| qRT-PCR | Quantitative Reverse Transcription Polymerase Chain Reaction |
| MYOD | Myogenic Differentiation Marker |
| MYOG | myogenin |
| PAX7 | Paired Box 7 |
| CCK-8 | Cell Counting Kit-8 |
| SD | Standard Deviation |
| TNF-α | tumor necrosis factor-alpha |
| NF-κB | Nuclear Factor Kappa B |
| PRP | platelet-rich plasma |
| α-SMA | Alpha-Smooth Muscle Actin |
| VEGF | vascular endothelial growth factor |
| PI3K/Akt | Phosphoinositide 3-Kinase/Protein Kinase B |
| sEVs | small extracellular vesicles |
| ATP | Adenosine Triphosphate |
| PGC-1α | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha |
| IL | Interleukin |
| Hz | hertz |
| INTEM | innervated tissue-engineered muscle |
| NT-3 | neurotrophin-3 |
| BDNF | Brain-Derived Neurotrophic Factor |
| AChRs | Acetylcholine Receptors |
| IFN-γ | Interferon-Gamma |
| IGF-1 | insulin-like growth factor-1 |
| TGF-β1 | transforming growth factor-beta 1 |
| HCT/P | Human Cells, Tissues, and Cellular and Tissue-Based Products |
| PMA | Premarket Approval |
| CDRH | Center for Devices and Radiological Health |
| CBER | Center for Biologics Evaluation and Research |
| CDER | Center for Drug Evaluation and Research |
| RMAT | Regenerative Medicine Advanced Therapy |
| GMP | good manufacturing practice |